New fat-busting drugs are helping public employees lose weight, but they're also busting budgets for local governments.

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

Houston Methodist doctors determined that Roberts had a spontaneous cerebrospinal fluid leak, a rare condition that can cause ...

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

Novo Nordisk has reported another significant criticality: the presence of unauthorized versions of its drugs on the US ...